Cássia Cristina Alves Gonçalves

ORCID: 0000-0003-2970-7889
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • Advanced biosensing and bioanalysis techniques
  • COVID-19 Clinical Research Studies
  • Poxvirus research and outbreaks
  • Bacillus and Francisella bacterial research
  • COVID-19 diagnosis using AI
  • Herpesvirus Infections and Treatments
  • Biosensors and Analytical Detection
  • Dental Research and COVID-19
  • Respiratory viral infections research
  • Zoonotic diseases and public health
  • Plant Virus Research Studies
  • COVID-19 Impact on Reproduction
  • T-cell and Retrovirus Studies
  • Nuclear Receptors and Signaling
  • Allergic Rhinitis and Sensitization
  • Long-Term Effects of COVID-19
  • Pregnancy and preeclampsia studies
  • Maternal Mental Health During Pregnancy and Postpartum

Universidade Federal do Rio de Janeiro
2021-2024

Átila Duque Rossi João Locke Ferreira de Araújo Tailah Bernardo de Almeida Marcelo Ribeiro‐Alves Camila de Almeida Velozo and 94 more Jéssica Maciel de Almeida Isabela de Carvalho Leitão Sâmila Natiane Ferreira Jéssica da Silva Oliveira Hugo José Alves Helena Toledo Scheid Débora S. Faffe Rafael Mello Galliez Renata Eliane de Ávila Gustavo Gomes Resende Mauro Martins Teixeira Alice Laschuk Herlinger Aliny dos Santos Carvalho André F. Santos Anna Carla Pinto Castiñeiras Bianca Isabelle Barreto Teixeira Bianca Ortiz da Silva Bruno Clarkson Bruno Eduardo Dematté Camila Nacif Camille Victória Leal Correia de Silva Carolina Moreira Voloch Caroline Macedo Nascimento Carolyne Lalucha Alves L. da Graça Cássia Cristina Alves Gonçalves Cíntia Policarpo Diana Mariani Ekaterini Simões Goudouri Elaine Sobral da Costa Elisângela Silva Enrico Bruno Riscarolli Érica Ramos dos Santos Nascimento Fabio Hecht Castro Medeiros Fábio L. Monteiro Fernanda Leitão dos Santos Fernando Luz de Castro Filipe Romero Rebello Moreira Francine Bittencourt Schiffler Gabriela Bergiante Kraychete Gabriele Silveira da Cunha Gisely Novaes Borges da Cunha Guilherme S. Lira Gustavo Peixoto Duarte da Silva Harrison James Westgarth Helena D.’Anunciação de Oliveira Helena Keito Toma Huang Fang Inês Corrêa Gonçalves Ingrid Camelo da Silva Isabela Labarba Carvalho de Almeida Joissy Aprigio de Oliveira Juliana Cazarin de Menezes Juliana T.S. Fortuna Karyne Ferreira Monteiro Kíssyla Harley Della Pascôa França Laura Zalcberg Renault Lendel Correia da Costa Leticia Averbug Correa Liane de Jesus Ribeiro Lídia Theodoro Boullosa Liliane Cavalcante Luana dos Santos Costa Lucas Matos Millioni Luciana Jesus da Costa Luiza M. Higa Marcela dos Santos Durães Marcelo Amaral de Souza Marcelo Calado de Paula Tôrres Mariana Freire Campos Mariana Quinto Mariane Talon de Menezes Marisa Souza Correia Mateus Rodrigues de Queiroz Matheus Augusto Calvano Cosentino Mayla Gabryele Miranda de Melo Mirela D’arc Ferreira da Costa Pedro Paz Raíssa Mirella dos Santos Cunha da Costa Raquel Fernandes Coelho Richard Araújo Maia Rodrigo Brindeiro Romina Carvalho Ferreira Sérgio Machado Lisboa Thamiris dos Santos Miranda Victor Akira Ota Victoria Cortes Bastos Viviane Guimarães Gomes Orlando da Costa Ferreira Júnior Terezinha Marta Pereira Pinto Castiñeiras Renan P. Souza Amílcar Tanuri Renato Santana Aguiar Shana Priscila Coutinho Barroso Cynthia Chester Cardoso

Abstract ACE2 and TMPRSS2 are key players on SARS-CoV-2 entry into host cells. However, it is still unclear whether expression levels of these factors could reflect disease severity. Here, a case–control study was conducted with 213 positive individuals where cases were defined as COVID-19 patients respiratory distress requiring oxygen support (N = 38) controls those mild to moderate symptoms the who did not need therapy along entire clinical course 175). mRNA evaluated in nasopharyngeal...

10.1038/s41598-021-88944-8 article EN cc-by Scientific Reports 2021-05-06

Community testing is a crucial tool for the early identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and transmission control. The emergence highly mutated Omicron variant (B.1.1.529) raised concerns about its primary site replication, impacting sample collection detectability by rapid antigen tests. We tested performance Panbio diagnostic test (Ag-RDT) using nasal oral specimens COVID-19 diagnosis in 192 symptomatic individuals, with quantitative...

10.1128/spectrum.01250-22 article EN Microbiology Spectrum 2022-06-02

There are some reports and case series addressing Coronavirus Disease 2019 (COVID-19) infections during pregnancy in upper income countries, but there few data on pregnant women with comorbid conditions low middle Countries. This study evaluated the proportion maternal neonatal outcomes associated SARS-CoV-2 infection among comorbidities. Participants were recruited consecutively order of admission to a maternity for Sociodemographic, clinical, laboratory prospectively collected...

10.3390/v13071277 article EN cc-by Viruses 2021-06-30

Current guidelines for patient isolation in COVID-19 cases recommend a symptom-based approach, averting the use of control real-time reverse transcription PCR (rRT-PCR) testing. However, we hypothesized that patients with persistently positive results by RT-PCR severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be potentially infectious prolonged time, even if immunocompetent and asymptomatic, which would demand longer social period than presently recommended. To test this...

10.1128/spectrum.00855-21 article EN cc-by Microbiology Spectrum 2021-11-17

Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) transmission occurs even among fully vaccinated individuals; thus, prompt identification of infected patients is central to control viral circulation. Antigen rapid diagnostic tests (Ag-RDTs) are highly specific, but sensitivity variable. Discordant RT-qPCR vs. Ag-RDT results reported, raising the question whether negative in positive samples could imply absence infectious viruses. To study relationship between with...

10.3389/fmicb.2022.912138 article EN cc-by Frontiers in Microbiology 2022-07-27

BACKGROUND In 2022, an outbreak of mpox that started in European countries spread worldwide through human-to-human transmission. Cases have been mostly mild, but severe clinical presentations reported. these cases, tecovirimat has the drug choice to treat patients with aggravated disease. OBJECTIVES Here we investigated susceptibility 18 isolates monkeypox virus (MPXV) obtained from different regions Brazil. METHODS Different concentrations were added cell monolayers infected each MPXV...

10.1590/0074-02760230056 article EN cc-by Memórias do Instituto Oswaldo Cruz 2023-01-01

BACKGROUND The high demand for adequate material the gold standard reverse transcription real-time polymerase chain reaction (RT-qPCR)-based diagnosis imposed by Coronavirus disease 2019 (COVID-19) pandemic, combined with inherent contamination risks healthcare workers during nasopharyngeal swab (NP) sample collection and discomfort it causes patients, brought need to identify alternative specimens suitable of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). OBJECTIVES aim this...

10.1590/0074-02760210085 article EN cc-by Memórias do Instituto Oswaldo Cruz 2021-01-01

Mpox is a zoonotic disease historically reported in Africa. Since 2003, limited outbreaks have occurred outside In 2022, the global spread of cases with sustained interhuman transmission and unusual features raised public health concerns. We explore mpox outbreak Rio de Janeiro (RJ) state, Brazil, an observational study mpox-suspected from June to December 2022. Data collection relied on healthcare notification form. Diagnosis was determined by MPXV-PCR. 46 confirmed cases, anti-VACV IgG...

10.22541/au.171221154.49449276/v1 preprint EN Authorea (Authorea) 2024-04-04

Abstract New SARS-CoV-2 variants are continually emerging and have the potential to present challenges public health responses worldwide. This report discusses early detection of lineage JN.2.5 (alias B.1.1.529.2.86.1.2.5) in Rio de Janeiro, Brazil. The variant was identified 2024 through viral whole-genome sequencing phylogenetic analysis, revealing that circulating strains genetic similarities sequences reported Canada, Poland, Belgium, England. While circulation diverse Omicron sub...

10.1101/2024.04.25.24306286 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-04-26

Background The diagnosis of allergic rhinitis (AR) is based on clinical manifestations and supported by a positive result for skin prick test (SPT) or serum specific immunoglobulin E (sIgE) antibodies to aeroallergens. Our objective was investigate the frequency patients with AR without evidence IgE sensitization.

10.1097/01.wox.0000411992.25922.6b article EN cc-by-nc-nd World Allergy Organization Journal 2012-02-01

Abstract SARS-CoV-2 transmission occurs even among fully vaccinated individuals; thus, prompt identification of infected patients is central to control viral circulation. Antigen rapid diagnostic tests (Ag-RDT) are highly specific, but sensitivity variable.Discordant RT-qPCR vs Ag-RDT results reported, raising the question whether negative in positive samples could imply absence infectious viruses. To study relationship between a with virological, molecular, and serological parameters, we...

10.1101/2022.03.17.22272008 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-03-20

Abstract Community testing is a crucial tool for the early identification of SARS-CoV-2 infection and transmission control. The emergence highly mutated Omicron variant (B.1.1.259) raised concerns about its primary site replication, impacting sample collection, detectability by rapid antigens tests. We tested Antigen Rapid Diagnostic Test (Ag-RDT) performance using nasal, oral, saliva specimens COVID-19 diagnosis in 192 symptomatic individuals, RT-qPCR from nasopharyngeal samples as Variant...

10.1101/2022.03.19.22272637 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-03-21
Coming Soon ...